 | • レポートコード：QYR9ST03287 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のG-CSFバイオシミラー市場について調査・分析し、以下の構成でお届け致します。G-CSFバイオシミラーの種類別には、ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子に、用途別には、血液疾患、腫瘍疾患、慢性及び自己免疫疾患、成長ホルモン欠乏症に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別G-CSFバイオシミラー売上データ ・地域別G-CSFバイオシミラー市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別G-CSFバイオシミラー市場規模：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子 ・用途別G-CSFバイオシミラー市場規模：血液疾患、腫瘍疾患、慢性及び自己免疫疾患、成長ホルモン欠乏症 ・主要メーカーの企業情報：Pfizer、Novartis、Roche、Merck & Co.、Sanofi、Johnson & Johnson、Gilead Science、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca、Bayer ・G-CSFバイオシミラーの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
The global G-CSF Biosimilars market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the G-CSF Biosimilars market based on company, product type, end user and key regions.
This report studies the global market size of G-CSF Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of G-CSF Biosimilars in these regions.
This research report categorizes the global G-CSF Biosimilars market by top players/brands, region, type and end user. This report also studies the global G-CSF Biosimilars market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Market size by Product
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Market size by End User
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global G-CSF Biosimilars market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of G-CSF Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global G-CSF Biosimilars companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of G-CSF Biosimilars submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of G-CSF Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of G-CSF Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 G-CSF Biosimilars Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global G-CSF Biosimilars Market Size Growth Rate by Product
1.4.2 Human Growth Hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal Antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.5 Market by End User
1.5.1 Global G-CSF Biosimilars Market Size Growth Rate by End User
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.5.4 Chronic And Autoimmune Diseases
1.5.5 Growth Hormone Deficiencies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global G-CSF Biosimilars Market Size
2.1.1 Global G-CSF Biosimilars Revenue 2014-2025
2.1.2 Global G-CSF Biosimilars Sales 2014-2025
2.2 G-CSF Biosimilars Growth Rate by Regions
2.2.1 Global G-CSF Biosimilars Sales by Regions
2.2.2 Global G-CSF Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 G-CSF Biosimilars Sales by Manufacturers
3.1.1 G-CSF Biosimilars Sales by Manufacturers
3.1.2 G-CSF Biosimilars Sales Market Share by Manufacturers
3.1.3 Global G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 G-CSF Biosimilars Revenue by Manufacturers
3.2.1 G-CSF Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
3.3 G-CSF Biosimilars Price by Manufacturers
3.4 G-CSF Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers G-CSF Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into G-CSF Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global G-CSF Biosimilars Sales by Product
4.2 Global G-CSF Biosimilars Revenue by Product
4.3 G-CSF Biosimilars Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global G-CSF Biosimilars Breakdown Data by End User
6 North America
6.1 North America G-CSF Biosimilars by Countries
6.1.1 North America G-CSF Biosimilars Sales by Countries
6.1.2 North America G-CSF Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America G-CSF Biosimilars by Product
6.3 North America G-CSF Biosimilars by End User
7 Europe
7.1 Europe G-CSF Biosimilars by Countries
7.1.1 Europe G-CSF Biosimilars Sales by Countries
7.1.2 Europe G-CSF Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe G-CSF Biosimilars by Product
7.3 Europe G-CSF Biosimilars by End User
8 Asia Pacific
8.1 Asia Pacific G-CSF Biosimilars by Countries
8.1.1 Asia Pacific G-CSF Biosimilars Sales by Countries
8.1.2 Asia Pacific G-CSF Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific G-CSF Biosimilars by Product
8.3 Asia Pacific G-CSF Biosimilars by End User
9 Central & South America
9.1 Central & South America G-CSF Biosimilars by Countries
9.1.1 Central & South America G-CSF Biosimilars Sales by Countries
9.1.2 Central & South America G-CSF Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America G-CSF Biosimilars by Product
9.3 Central & South America G-CSF Biosimilars by End User
10 Middle East and Africa
10.1 Middle East and Africa G-CSF Biosimilars by Countries
10.1.1 Middle East and Africa G-CSF Biosimilars Sales by Countries
10.1.2 Middle East and Africa G-CSF Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa G-CSF Biosimilars by Product
10.3 Middle East and Africa G-CSF Biosimilars by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer G-CSF Biosimilars Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis G-CSF Biosimilars Products Offered
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche G-CSF Biosimilars Products Offered
11.3.5 Roche Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Details
11.4.2 Company Business Overview
11.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck & Co. G-CSF Biosimilars Products Offered
11.4.5 Merck & Co. Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi G-CSF Biosimilars Products Offered
11.5.5 Sanofi Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Science
11.7.1 Gilead Science Company Details
11.7.2 Company Business Overview
11.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Gilead Science G-CSF Biosimilars Products Offered
11.7.5 Gilead Science Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 Company Business Overview
11.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 Company Business Overview
11.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AbbVie G-CSF Biosimilars Products Offered
11.9.5 AbbVie Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Business Overview
11.10.3 Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Amgen G-CSF Biosimilars Products Offered
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.12 Bayer
12 Future Forecast
12.1 G-CSF Biosimilars Market Forecast by Regions
12.1.1 Global G-CSF Biosimilars Sales Forecast by Regions 2019-2025
12.1.2 Global G-CSF Biosimilars Revenue Forecast by Regions 2019-2025
12.2 G-CSF Biosimilars Market Forecast by Product
12.2.1 Global G-CSF Biosimilars Sales Forecast by Product 2019-2025
12.2.2 Global G-CSF Biosimilars Revenue Forecast by Product 2019-2025
12.3 G-CSF Biosimilars Market Forecast by End User
12.4 North America G-CSF Biosimilars Forecast
12.5 Europe G-CSF Biosimilars Forecast
12.6 Asia Pacific G-CSF Biosimilars Forecast
12.7 Central & South America G-CSF Biosimilars Forecast
12.8 Middle East and Africa G-CSF Biosimilars Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 G-CSF Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure G-CSF Biosimilars Product Picture
Table G-CSF Biosimilars Market Segments
Table Key Manufacturers G-CSF Biosimilars Covered
Table Global G-CSF Biosimilars Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$)
Figure Global G-CSF Biosimilars Sales Market Share by Product 2014-2025
Figure Human Growth Hormone Product Picture
Table Major Manufacturers of Human Growth Hormone
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Interferon Product Picture
Table Major Manufacturers of Interferon
Figure Granulocyte-Colony Stimulating Factor Product Picture
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor
Table Global G-CSF Biosimilars Market Size Growth Rate by End User 2019-2025 (Units)
Figure Blood Disorders
Figure Oncology Diseases
Figure Chronic And Autoimmune Diseases
Figure Growth Hormone Deficiencies
Figure G-CSF Biosimilars Report Years Considered
Figure Global G-CSF Biosimilars Market Size 2014-2025 (Million US$)
Figure Global G-CSF Biosimilars Sales 2014-2025 (Units)
Table Global G-CSF Biosimilars Market Size by Regions 2014-2019 (Units) & (Million US$)
Table Global G-CSF Biosimilars Sales by Regions 2014-2019 (Units)
Table Global G-CSF Biosimilars Sales Market Share by Regions 2014-2019
Figure Global G-CSF Biosimilars Sales Market Share by Regions 2014-2019
Figure 2018 Global G-CSF Biosimilars Sales Market Share by Regions
Table Global G-CSF Biosimilars Revenue by Regions 2014-2019 (Million US$)
Table Global G-CSF Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global G-CSF Biosimilars Revenue Market Share by Regions 2014-2019
Figure 2018 Global G-CSF Biosimilars Revenue Market Share by Regions
Table Global G-CSF Biosimilars Sales by Manufacturers (2014-2019) (Units)
Table Global G-CSF Biosimilars Sales Share by Manufacturers (2014-2019)
Figure Global G-CSF Biosimilars Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table G-CSF Biosimilars Revenue by Manufacturers (2014-2019) (Million USD)
Table G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
Figure G-CSF Biosimilars Value Share by Manufacturers in 2018
Table Key Manufacturers G-CSF Biosimilars Price (2014-2019) (USD/Unit)
Table G-CSF Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers G-CSF Biosimilars Product Type
Table Date of International Manufacturers Enter into G-CSF Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table Global G-CSF Biosimilars Sales Share by Product (2014-2019)
Figure Global G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure Global G-CSF Biosimilars Sales Market Share by Product in 2018
Table Global G-CSF Biosimilars Revenue by Product (2014-2019) (Million US$)
Table Global G-CSF Biosimilars Revenue Share by Product (2014-2019)
Figure Global G-CSF Biosimilars Revenue Market Share by Product (2014-2019)
Figure Global G-CSF Biosimilars Revenue Market Share by Product in 2018
Table G-CSF Biosimilars Price by Product 2014-2019 (USD/Unit)
Table Global G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table Global G-CSF Biosimilars Sales Share by End User (2014-2019)
Figure Global Sales G-CSF Biosimilars Market Share by End User (2014-2019)
Figure Global Sales G-CSF Biosimilars Market Share by End User in 2018
Figure North America G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
Figure North America G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table North America G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
Table North America G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 North America G-CSF Biosimilars Sales Market Share by Countries
Table North America G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table North America G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 North America G-CSF Biosimilars Revenue Market Share by Countries
Figure United States G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure United States G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Units)
Figure Canada G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Canada G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Mexico G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table North America G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table North America G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 North America G-CSF Biosimilars Market Share by Product
Table North America G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table North America G-CSF Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 North America G-CSF Biosimilars Market Share by End User
Figure Europe G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
Figure Europe G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Europe G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
Table Europe G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Europe G-CSF Biosimilars Sales Market Share by Countries
Table Europe G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Europe G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe G-CSF Biosimilars Revenue Market Share by Countries
Figure Germany G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Germany G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure France G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure France G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure UK G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure UK G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Italy G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Russia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Europe G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table Europe G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Europe G-CSF Biosimilars Market Share by Product
Table Europe G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table Europe G-CSF Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Europe G-CSF Biosimilars Market Share by End User
Figure Asia Pacific G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
Figure Asia Pacific G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
Table Asia Pacific G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific G-CSF Biosimilars Sales Market Share by Countries
Table Asia Pacific G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific G-CSF Biosimilars Revenue Market Share by Countries
Figure China G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure China G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Japan G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Korea G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure India G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure India G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Australia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Indonesia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Malaysia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Philippines G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Thailand G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Vietnam G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Singapore G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table Asia Pacific G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific G-CSF Biosimilars Market Share by Product
Table Asia Pacific G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table Asia Pacific G-CSF Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific G-CSF Biosimilars Market Share by End User
Figure Central & South America G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
Figure Central & South America G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
Table Central & South America G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America G-CSF Biosimilars Sales Market Share by Countries
Table Central & South America G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Central & South America G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America G-CSF Biosimilars Revenue Market Share by Countries
Figure Brazil G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Brazil G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Argentina G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table Central & South America G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America G-CSF Biosimilars Market Share by Product
Table Central & South America G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table Central & South America G-CSF Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America G-CSF Biosimilars Market Share by End User
Figure Middle East and Africa G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
Figure Middle East and Africa G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
Table Middle East and Africa G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa G-CSF Biosimilars Sales Market Share by Countries
Table Middle East and Africa G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa G-CSF Biosimilars Revenue Market Share by Countries
Figure GCC Countries G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure GCC Countries G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Turkey G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure Egypt G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
Figure South Africa G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa G-CSF Biosimilars Sales by Product (2014-2019) (Units)
Table Middle East and Africa G-CSF Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa G-CSF Biosimilars Market Share by Product
Table Middle East and Africa G-CSF Biosimilars Sales by End User (2014-2019) (Units)
Table Middle East and Africa G-CSF Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa G-CSF Biosimilars Market Share by End User
Table Pfizer Company Details
Table Pfizer G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Roche Company Details
Table Roche G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Merck & Co. Company Details
Table Merck & Co. G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Recent Development
Table Sanofi Company Details
Table Sanofi G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Gilead Science Company Details
Table Gilead Science G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Science Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table AbbVie Company Details
Table AbbVie G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table Bayer Company Details
Table Global G-CSF Biosimilars Sales Forecast by Regions 2019-2025 (Units)
Table Global G-CSF Biosimilars Sales Market Share Forecast by Regions 2019-2025
Table Global G-CSF Biosimilars Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global G-CSF Biosimilars Revenue Market Share Forecast by Regions 2019-2025
Table Global G-CSF Biosimilars Sales Forecast by Product 2019-2025 (Units)
Table Global G-CSF Biosimilars Sales Market Share Forecast by Product 2019-2025
Table Global G-CSF Biosimilars Revenue Forecast by Product 2019-2025 (Million US$)
Table Global G-CSF Biosimilars Revenue Market Share Forecast by Product 2019-2025
Table Global G-CSF Biosimilars Sales Forecast by End User 2019-2025 (Units)
Table Global G-CSF Biosimilars Sales Market Share Forecast by End User 2019-2025
Figure North America G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
Figure North America G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
Figure Europe G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
Figure Asia Pacific G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
Figure Central & South America G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
Figure Middle East and Africa G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table G-CSF Biosimilars Value Chain
Table G-CSF Biosimilars Customers List
Table G-CSF Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
バイオシミラー/生物学的製剤の世界市場：市場規模・現状・予測 Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. In 2018, the global Biosimilars/follow…- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 世界のメラノサイト刺激ホルモン受容体市場：専門的調査 The global Melanocyte Stimulating Hormone Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Melanocyte Stimulating Hormone Receptor volume and value at global level, regional level and compan…
- バイオシミラーの世界市場：インサイト・予測 A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference produ…
- がん支持療法の世界市場：インサイト・予測 The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.With growing prevalence of cancer,…